You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

Details for Patent: 9,499,546


✉ Email this page to a colleague

« Back to Dashboard


Title:Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
Abstract: The invention relates to an improved process for preparing enantiomerically pure 8-(3-aminopiperidin-1-yl)-xanthines.
Inventor(s): Pfrengle; Waldemar (Biberach an der Riss, DE), Pachur; Thorsten (Biberach an der Riss, DE), Nicola; Thomas (Ingelheim am Rhein, DE), Duran; Adil (Biberach an der Riss, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Filing Date:Oct 06, 2014
Application Number:14/507,190
Claims:1. A process for preparing a medicament comprising a first compound of formula ##STR00015## or a physiologically acceptable salt thereof, the process comprising deprotecting a second compound of formula ##STR00016## by detaching the phthalyl protecting group to provide the first compound, wherein R.sup.1 is a (4-methylquinazolin-2-yl)methyl, (3-methylisoquinolin-1-yl)methyl or (3-cyanopyridin-2-yl)methyl group, R.sup.2 is a methyl group, and R.sup.3 is a 2-butyn-1-yl group; and combining the first compound with one or more inert carriers and/or diluents.

2. The process according to claim 1 wherein R.sup.1 is a (4-methylquinazolin-2-yl)methyl.

3. The process according to claim 2, wherein the phthalyl protecting group of the second compound is detached in the presence of ethanolamine.

4. The process according to claim 2, wherein the phthalyl protecting group of the second compound is detached in the presence of (a) ethanolamine and toluene or (b) ethanolamine and a mixture of tetrahydrofuran and water.

5. The process according to claim 2, further comprising crystallizing the first compound from ethanol or methanol.

6. The process according to claim 2, further comprising crystallizing the first compound from ethanol.

7. The process according to claim 2, wherein the step of detaching the phthalyl protecting group of the second compound is carried out the presence of (a) ethanolamine and toluene or (b) ethanolamine and a mixture of tetrahydrofuran and water, to provide the first compound, and the process further comprises crystallizing the first compound from ethanol or methanol.

8. The process according to claim 7, wherein the first compound is crystallized from ethanol.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.